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Background: Contractures of the knee joint cause disability and handicap. Recovering range of motion is recognized
by arthritic patients as their preference for improved health outcome secondary only to pain management. Clinical and
experimental studies provide evidence that the posterior knee capsule prevents the knee from achieving full extension.
This study was undertaken to investigate the dynamic changes of the joint capsule transcriptome during the
progression of knee joint contractures induced by immobilization. We performed a microarray analysis of genes
expressed in the posterior knee joint capsule following induction of a flexion contracture by rigidly immobilizing
the rat knee joint over a time-course of 16 weeks. Fold changes of expression values were measured and co-expressed
genes were identified by clustering based on time-series analysis. Genes associated with immobilization were further
analyzed to reveal pathways and biological significance and validated by immunohistochemistry on sagittal sections of
knee joints.
Results: Changes in expression with a minimum of 1.5 fold changes were dominated by a decrease in expression for
7732 probe sets occurring at week 8 while the expression of 2251 probe sets increased. Clusters of genes with similar
profiles of expression included a total of 162 genes displaying at least a 2 fold change compared to week 1. Functional
analysis revealed ontology categories corresponding to triglyceride metabolism, extracellular matrix and muscle
contraction. The altered expression of selected genes involved in the triglyceride biosynthesis pathway; AGPAT-9,
and of the genes P4HB and HSP47, both involved in collagen synthesis, was confirmed by immunohistochemistry.
Conclusions: Gene expression in the knee joint capsule was sensitive to joint immobility and provided insights into
molecular mechanisms relevant to the pathophysiology of knee flexion contractures. Capsule responses to
immobilization was dynamic and characterized by modulation of at least three reaction pathways; down
regulation of triglyceride biosynthesis, alteration of extracellular matrix degradation and muscle contraction gene
expression. The posterior knee capsule may deploy tissue-specific patterns of mRNA regulatory responses to
immobilization. The identification of altered expression of genes and biochemical pathways in the joint capsule
provides potential targets for the therapy of knee flexion contractures.
Keywords: Joint contracture, Immobilization, Knee joint capsule, Gene expression, RatBackground
Many joint diseases, including both inflammatory and
non-inflammatory types, are associated with a reduced
mobility of the affected joints. The inability of the joint
to range through its full passive motion is referred to as
a contracture, the nature of which is chronic and treated* Correspondence: olaneuvi@uottawa.ca
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unless otherwise stated.with limited success [1, 2]. For rheumatoid arthritis
(RA) patients, the lack of complete joint mobility is the
second most troublesome problem after pain and results
in functional impairment and limitation of activities [3].
Consistently, the second preference for improvement of
health for RA patients is mobility with emphasis on
walking and handling activities [4]. Knee contractures
are also a complication of arthroplasty (TKA) preventing
the knee joint from achieving the full extension that is
essential for normal walking [5–7]. Postoperative manualThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(ROM) but pain and the high demands of this prolonged
rehabilitation treatment can hamper the efforts and pa-
tients may become disabled [8]. Revision surgery can pro-
vide temporary improvement in some cases but the risk of
postsurgical complications is high [9]. Overall, joint con-
tractures have limited reversibility, permanently impairing
the physical ability of individuals.
The etiology of joint contractures, whether in associ-
ation with arthritic diseases or not, remains unknown and
few studies have been conducted to identify causal factors.
A retrospective review of data collected from patients
undergoing primary TKA reported a 3.6 % incidence of
flexion contractures at 2 years postoperative [6]. Although
at low percentage, more than 4630 new patients develop
flexion contractures after TKA every year in the United
States based on the 130 000 knee replacements performed
for patients with disabling arthritis of the knee. The two
most important contributors to flexion contractures
following primary TKA were identified as bone deform-
ity and soft tissue tightness [6, 8]. In a different clinical
context, joint contractures were prevalent in patients
admitted to intensive care units (ICU) and with a stay
longer than 2 weeks [10]. A 34 % incidence of joint con-
tracture in a large joint was reported indicating that
immobility was an important etiologic factor for joint
contractures. Time spent in the ICU was a significant risk
factor for contracture; a stay of 8 weeks or longer was as-
sociated with a significantly greater risk of any joint con-
tracture than a stay of 2 to 3 weeks [11]. An animal model
of joint contractures was developed to evaluate the causal
role of prolonged joint immobility and to study the
pathophysiology involved [12]. Both clinical and experi-
mental evidence support the notion of immobilization
causing joint contractures over time.
The contribution of time in the initiation, progression,
and severity of joint contractures induced by immobilization
was confirmed and the loss of ROM of rat knees immobi-
lized in flexion over a 32-week time course that was grad-
ual over the first 8 weeks and then reached a plateau
[12]. The immobilization device was implanted outside
the joint to preserve the integrity of joint tissue struc-
tures and prevented the knee from achieving full ex-
tension. Upon removal of the immobilization device,
the ROM was measured and results indicated that a
fixed flexion contracture was present [12, 13]. Section-
ing of the posterior knee joint muscles did not restore
the full ROM and limitation was attributed to the cap-
sule [14]. Histological analysis of knee sections cor-
roborated the biomechanical limitation mediated by
the posterior capsule and a reduction of the synovial
length was measured [15]. The progressive loss of the
knee ROM over time was indicative of a dynamic
process leading to structural changes of the capsuletissue and the next step was to identify the molecular
events involved.
The aim of the current study was to establish the dy-
namic profile of gene expression in the posterior knee
capsule tissue over the course of the development of a
joint contracture induced by immobilization.
Results
From the initial 80 rats operated, two were eliminated
because of a wound infection. Extracted RNA samples
from the remaining 78 posterior knee capsules were sub-
mitted to quality control analysis and 20 sham-operated
and 20 immobilized samples were selected for micro-
array analysis on the basis of similar RNA yield ranging
between 50 and 80 ng/μl.
Fold changes in gene expression
The complete data sets of pre-processed data included
expression values for 16712 probe sets measured in both
sham-operated and immobilized knee capsules (Fig. 1). To
appreciate fold changes in gene expression, week 1 was set
as the reference point and ratios were analyzed independ-
ently for each series. Ratios with a minimum of a 1.5 fold
change were binned in two categories; 1.5 to 2.0 and 2.0
more than. The direction and magnitude of fold changes
in expression were dominated by a reduction in expression
for 7732 probe sets compared to 2251 probe sets increasing
(Fig. 2). Expression changes were time dependent; a decrease
occurred more frequently at week 8 for 92.5 % (=7141/7732
probe sets) of the total probe sets decreasing at any time
point. Increase in expression was observed at week 2 and 4
for 1736 probe sets or 77.1 % (1736/2251).
Time-related patterns of gene expression
To capture gene expression dynamics, CAGED algorithm
was applied to log 2 transformed data included in the
complete data sets. Probe sets with at least one time point
observation above or below 2 fold change compared to
week 1, were considered in the clustering analysis and
summed to a total of 2322 for the sham operated group
and to 3516 for the immobilization group (Fig. 1). Cluster-
ing of sham-operated data identified 13 clusters each in-
cluding genes with a similar profile of expression. Eight
clusters with center values, in log 2 base, higher than 1 or
lower than −1, were selected for in depth analysis. The total
number of probe sets included in the eight sham-operated
clusters was equal to 493 corresponding to 335 differ-
ent genes. Cluster analysis of the immobilization gene-
expression time series identified 8 distinct clusters. Cluster
center values were used to select clusters for in depth ana-
lysis and additional grouping. Six clusters were assigned to
one of the three major temporal groups according to in-
creased (clusters 1 and 7), variable (clusters 5 and 6), or
decreased expression (clusters 4 and 8) (Fig. 3). The total
Fig. 1 Experimental design to identify capsule genes associated with immobilization-induced joint contractures. After preprocessing raw microarray data,
intensity values of probe sets measured at 2, 4, 8, and 16 weeks were compared to results measured at week 1 to determine the fold change
in expression. Probe sets counts were separated into four bins: up-regulated by a fold change of 1.5 to 2.0 or above 2.0, and down-regulated
by a fold change of −1.5 to −2 or more than −2. The number of probe sets included in each bin is indicated on the Y axis for individual time points
indicated on the X axis
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bility group was 396 corresponding to 288 genes.Selection of capsule immobilization genes
The list of probes sets included in all selected clusters
from sham-operated and immobilized samples were com-
pared to identify similarities (Fig. 1) and 171 probe sets,
corresponding to 126 genes, were found in both groups.
Identified genes with a profile of differential expression
common to both groups; immobilization and sham-
operated, although not specific to knee flexion contrac-
tures, could play a role in the capsular changes leading
to a restriction of knee ROM induced by immobility
but were not further studied. The number of probe sets
included in the immobilization group only was equal to
225 corresponding to 162 different genes that were fur-
ther analyzed to obtain biological insight. The aim here
was to study the temporal changes in gene expression
associated with immobilization and a total of 162 genes
displayed dynamic changes of expression associated with
the progression of knee joint contracture over the time-
course of 16 weeks.Functional knowledge base
The list of 162 immobilization genes included in selected
clusters was analyzed for enrichment of biological func-
tions. A GO enrichment analysis was conducted using
DAVID/EASE (version 6.7) software and Affymetrix probe
ID notations. Immobilization genes were classified into
three different categories belonging to Biological Process,
Molecular Function and Cellular Component. The two
most represented GO terms were: extracellular matrix
structure and organization and lipid biosynthetic and
metabolic process. Immobilization genes included in GO
terms groups were compared to the list of genes included
in clusters generated by CAGED analysis (Table 1). Inter-
estingly, the majority of the genes included in the most
represented GO terms belonged to cluster 4 from CAGED
analysis; 24 of 36 (67 %) genes for the Biological Process
and 36 of 63 (57 %) genes for Cellular Component.
The immobilization genes were mapped to their corre-
sponding metabolic pathways using KEGG pathway ana-
lysis and the Reactome software. Most represented KEGG
pathways included dilated cardiomyopathy, extracellular
matrix, and biosynthesis of fatty acids (Table 1). Genes in-
cluded in the most represented KEGG pathways were
Fig. 2 Fold changes in gene expression in the capsule of immobilized knee joints. After pre-processing signal intensities from the immobilization
group, expression levels at 2, 4, 8, and 16 weeks were log 2 transformed and values compared to the log 2 transformed results at week 1 using
the CAGED algorithm to cluster genes with similar profiles of expression. Eight expression clusters were identified and clusters 2 and 3 had
median fold changes between −2 and 2 and were thus eliminated. For the remaining 6 clusters, cluster centers corresponding to log2 value over
the time course of immobilization-induced knee joint contracture were plotted over the time-course
Fig. 3 Time-series analysis to identify clusters of expression associated with immobilization. Posterior knee capsule samples from sham-operated
and immobilized rats joints were harvested at time points of 1, 2, 4, 8, and 16 weeks and were subjected to genome-wide microarray analysis.
Expression values from the sham and immobilized samples were analyzed separately to quantify fold changes and to cluster genes with similar
profiles of expression. The two lists of genes included in clusters generated from temporal expression analysis were compared to identify
similarities. Genes unique to immobilization were analyzed in depth to gain insight on the biological significance by integration of CAGED,
GO, KEGG, Reactome, and literature biocuration results. Immunohistochemistry was used to validate the microarray results for selected genes
Wong et al. BMC Musculoskeletal Disorders  (2015) 16:125 Page 4 of 13
Table 1 Functional interpretation of genes associated with immobilization-induced knee joint contractures. The lists of genes included in all clusters identified
for the sham-operated and for the immobilization group were compared for similarities. Genes associated with the immobilization intervention only were
submitted to Gene Ontology (GO), KEGG Pathways, and Reactome Pathway analysis. Analyses were performed using default settings for terms of the GO
Biological Processes (BP_FAT), GO Molecular Function categories (MF_FAT) and GO Cellular Component (CC_FAT) (not shown). Significant GO terms and
pathways from KEGG and Reactome mapping are listed. The list of genes included in each enriched terms was compared to immobilization genes identified
by clustering using CAGED application. Numbers in parenthesis indicate the number of common probe sets between enriched terms and CAGED clusters
GO Terms P-value CAGED cluster (# of
probes in cluster)
KEGG Pathways P-value CAGED cluster (# of
probes in cluster)
Reactome Pathways P-value CAGED cluster (# of
probes in cluster)
Biological Process Dilated cardiomyopathy 4.8 x 10−4 1 (2) Muscle contraction 5.0 x 10−10 1 (3)
4 (3) 4 (3)
5 (4) 5 (4)
8 (1) 8 (1)
Extracellular structure
organization
9.2 x 10−7 1 (5) ECM-receptor interaction 2.0 x 10−3 1 (2) Triglyceride biosynthesis 3.6 x 10−7 4 (9)
4 (4) 4 (1)
5 (1) 6 (3)
6 (2) 8 (1)
Lipid biosynthetic
process
1.9 x 10−5 1 (3) Hypertrophic cardiomyopathy
(HCM)
2.4 x 10−3 1 (2) Gelatin degradation by MMPs 3.8 x 10−7 1 (2)
4 (12) 4 (2) 4 (3)




2.0 x 10−5 1 (1) Cardiac muscle contraction 1.1 x 10−2 4 (2) Collagen type XI degradation
by MMPs
9.7 x 10−7 1 (2)
4 (8) 5 (4) 4 (2)
8 (1) 6 (1)
Cellular Component Focal adhesion 2.2 x 10−2 1 (3) Degradation of collagen 1.3 x 10−6 1 (2)
4 (1)
6 (3) 4 (5)
8 (1) 6 (2)
Extracellular region
part
8.6 x 10−9 1 (7) Biosynthesis of unsaturated
fatty acids
2.9 x 10−2 4 (3) Collagen type X degradation
by MMPs
2.2 x 10−6 4 (2)




Extracellular matrix 2.0 x 10−8 1 (4) Complement and coagulation
cascades
4.4 x 10−2 4 (3) ATP Hydrolysis by Myosin; Myosin
Binds ATP; Calcium Binds Caldesmon;
Release of ADP From Myosin
4.8 x 10−6 1 (3)
4 (9) 5 (1) 4 (1)
6 (4) 5 (2)
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majority, 36 of 63 (=57 %) genes, belonged to cluster 4
(Table 1). The most represented Reactome pathways in-
cluded: muscle contraction, triglyceride biosynthesis, and
collagen degradation (Table 1). The list of genes included
in the most represented Reactome pathways was compared
to clustering results and the majority, 31 of the 56 genes or
55 %, belonged to CAGED cluster 4.
Genes and pathways of the capsule response to
immobilization
The list of enriched genes related to the biosynthesis of
triglycerides included: Fasn, Agpat2, Ggat2, Acaca, Gpd1,
Elov1, and Acsl1. All seven genes displayed a reduction
in expression over the immobilization time course and
belonged to cluster 4 of CAGED analysis. For the bio-
logical term extracellular structure and degradation,
genes with an altered profile of expression included:
MMP3, MMP9, MMP13, Col2a1, Col10a1, Col11a1,
Agt, Alb, Cdh1, Cdh2, Cfd, Chad, Ibsp, Ky, Myh11, Obp3,
Pcsk6, Tf, Tnfrsf11b, Tnn, and Vit. Of particular interest
for the capsule tissue are the metalloproteinase genes
(MMP), all displaying a profile of decreased expression
during the progression of the knee contracture. The colla-
gen genes enriched in the immobilization group displayed
either variable or reduced expression over the time-course.
Human capsule gene enrichment analysis: literature
searching
Available data sources were searched to build a target net-
work to gain further understanding of the gene expression
changes taking place in the knee capsule of contractured
joints. To our knowledge, no published literature or data
deposited in public databases on genome-wide expression
of the knee joint capsule tissue is currently available. An
enrichment analysis for human joint diseases characterized
by the presence of either joint contractures or joint hyper
laxity was established and included 122 genes. Results from
the enrichment analysis were compared to the list of genes
generated from our study on immobilization-induced knee
joint contractures and common genes included: Col2a1,
Col10a1, Col11a1, TNNT1, TNNT2, TPM3, and PLP1.
Immunohistochemistry validation
Three genes enriched in the triglyceride biosynthesis path-
way were selected for validation of gene expression changes
and included AGPAT-9 (1- acylglycerol-3-phosphate O-
acyltransferase 9), P4HB (protein disulfide isomerase is
a subunit of the enzyme prolyl 4-hydroxylase) and PCK1
(phosphoenolpyruvate carboxykinase 1). AGPAT-9 protein
and transcripts levels varied with a similar profile of
decreased expression (Fig. 4 panel b and Fig. 5). The
difference in protein staining for AGPAT-9 between
sham-operated and immobilized capsule was statisticallysignificant at 2 weeks (p = 0.025). P4HB is a microsomal
triglyceride transfer protein involved in intracellular lipid
exchange [16] and levels of the corresponding tran-
script and protein decreased over the time-course (Fig. 4
panel c). Statistically different amounts of protein stain-
ing were detected at weeks 8 (p = 0.015) and 16 (p =
0.013). Profiles of expression of PCK1 transcript and
protein were different; mRNA levels decreased while pro-
tein levels presented a mixed profile of expression over
time; low levels were measured at week 2 and 8 with ap-
proximately 10 % of cells staining positively and approxi-
mately 40 % of cells stained positively at week 4 and 16
(Fig. 4 panel a). The difference in protein staining for
PCK1 was statistically significant at 8 weeks (p = 0.0009).
Changes in protein levels were not determined at week 1
while gene expression values represent a ratio of expres-
sion with week 1 used as a reference.
P4HB gene was also enriched in the extracellular matrix
synthesis pathway and was involved in the post transla-
tional modification of collagens [17]. P4HB transcript and
protein levels both decreased over the time-course (Fig. 4
panel c). HSP47 is involved in the folding of collagens [18],
and although not included in the list of genes displaying al-
tered expression in association with immobilization, it was
selected based on previous published histological data gen-
erated from the rat model of knee flexion contractures and
reporting an increase of collagen I staining and a decrease
of collagen III [19]. Both levels of transcript and staining
intensity of HSP47 decreased over the time-course of
immobilization-induced knee joint contractures (Fig. 4
panel d). A significant difference in HSP47 protein stain-
ing between immobilized and sham-operated capsule was
detected at week 4 (p = 0.037).Discussion
All immobilized rat knees developed a contracture and
structural and genetic changes varied with a similar dy-
namic. The loss of ROM was gradual during the first
8 weeks of continuous immobilization then a plateau is
reached despite extending the immobilization period to
32 weeks [12]. The posterior knee capsule tissue responded
to immobilization and deployed a profile of gene expres-
sion characterized by time-dependent changes dominated
by reduced expression for 92.5 % of genes at week 8. The
surface of the articular cartilage became irregular after
2 weeks and progressed rapidly to plateau after 8 weeks
[20, 21]. For patients, time spent in the ICU was a risk
factor for contractures and a stay of 8 weeks or longer
had an odds ratio of 7:1 to develop joint contractures
relative to a stay of 2 to 3 weeks [10]. Clinical and ex-
perimental observations are indicative of a negative im-
pact of immobilization on the knee joint characterized by
changes affecting function, structure and genetic, and with
Fig. 4 Validation of immobilization associated genes: immunohistochemistry. Quantification of immunohistochemistry staining of PCK1 (panel A),
AGPAT-9 (panel B), P4HB (panel C), and HSP47 (panel D) in the posterior knee capsule from the rat time course experiment. The average count of
each field between two independent examiners is plotted along with a median line for each experimental group. Statistical significance (p < 0.05)
in levels of protein staining is indicated with*. Values below individual graphs represent pre-processed median mRNA expression levels for the
corresponding probe sets
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week 8 and a plateau.
Sampling the knee capsule at multiple time points pro-
vided a view of the sequence of gene expression events
that took place during the process of developing knee
flexion contractures. Time-series analysis captured an early
increase in gene expression measured at 2 and 4 weeks
and a later decrease at week 8. Whether there is a link be-
tween early and late events of gene expression measured in
the current study remains to be determined. Assessing
changes in expression within the immobilization group as
opposed to using a paired design in which sham-operated
and immobilized are compared at similar time points was
strategized to account for the effect of surgery and reduced
the heterogeneity of samples.The integration of the functional analysis results for
the 162 immobilization-only genes revealed enrichment
of genes involved in lipid synthesis and extracellular matrix
pathways. While modulation of expression of genes associ-
ated with extracellular matrix pathways was expected in
connective tissues such as the knee capsule, the enrich-
ment of genes in the lipid pathways was unexpected
[22]. Genes identified as part of triglyceride synthesis
all clustered together (cluster 4) and showed a decrease
in expression over time. Interestingly, a case of a patient
with congenital generalized lipodystrophy type 1 with a
mutation in the AGPAT-2 gene has been reported to have
joint contractures [23]. Other inflammatory lipody-
strophies and mandibuloacral dysplasia have also been as-
sociated with joint contractures [24]. While a decrease in
Fig. 5 Immunostaining of AGPAT-9 in the posterior capsule of rat knee joints. Haematoxylin staining (blue) and DAB staining (brown) of AGPAT-9
antigen in immobilized and sham-operated rats at time points of 2, 4, 8, and 16 weeks. Cells stained with DAB were considered positively stained.
Images were captured with a Marlin F080C digital camera (Allied Vision Technologies) with AVT Smartview 1.5.1 software, magnified to 100X
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toxicity, mitochondrial dysfunction and oxidative stress
[25], a potential causative role of triglyceride pathways in
joint contractures has yet to be investigated.
The immobilization-only genes included collagen genes
Col2a1, Col10a1, and Col11a1, all previously associated
with human genetic disorders with altered joint mobility
[26–31]. Col11a1, a fibrillar collagen, had a profile of
expression that decreased over time while Col2a1 and
Col10a1, both found in hyaline cartilage, increased in
early time points and decreased at later time points. The
role of those small collagens in capsule elasticity remains
to be discovered. The principal collagens in the capsule,
collagen types I and III, are influenced by immobilization;
an increase in collagen I and a decrease in collagen III
staining were previously documented [19]. In the current
study, the transcripts for both Col1 (Col1a1 and Col1a2)
and Col3 (Col3a1) were expressed at very high levels at
week 2 and 4, possibly as an effort to remodel the capsuleextra-cellular matrix, and reduced at week 8 and 16 when
the contracture became chronic. Changes in mRNA levels
parallel the protein changes for collagen III but not for
collagen I. The regulation of collagen synthesis and matur-
ation was not limited to transcriptional regulation but also
modulated by the activity of the molecular chaperone
Hsp47 [18]. Levels of Hsp47 mRNA and proteins both de-
creased at week 8 and 16 in samples from immobilized
knee joints. A role for collagen associated protein in the
establishment of capsule contractures was supported by
the identification of chondroadherin (CHAD) in the clus-
ter analysis. CHAD is a cell-binding protein found in car-
tilage and other tissues and is known to strongly associate
with collagen, specifically collagen type II [32, 33].
Several extra-cellular matrix degrading metalloprotein-
ases were also enriched in the immobilization-only gene
list: MMP3, MMP9, and MMP13. MMP9, which degrades
type IV and type V collagens, showed an increase in ex-
pression over time [34, 35]. MMP3 and MMP13, which
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matrix proteins, showed a decrease in expression over the
time course [36–39]. Cadherin-1 and cadherin-2, both up
regulated over time in the capsule of immobilized knee
joints, have important roles in cell adhesion [40, 41].
Enhanced cell adhesion mechanisms could explain the
reduced synovial intima length resulting when the folds
of the posterior capsule, relaxed when the knee joint is
immobilized in flexion, adhere to each other and fuse,
and leading to mechanical limitation [15, 42].
More studies are required to demonstrate the causal
role of the identified genes and pathways in the limita-
tion of knee ROM induced by immobility over time. Pre-
vious work to characterize the pathophysiology of knee
flexion contractures includes the examination of sagittal
rat knee sections prepared from immobilized and sham
operated rat knees using light microscopy. Changes in-
clude the presence of surface irregularities of the ar-
ticular cartilage, a reduced number of chondrocytes and
reduced collagen matrix staining [20, 21]. In the knee
posterior capsule, a decreased number of proliferating
synoviocytes and increased intima adhesions were ob-
served [15, 42]. In the current study, the manifestations
of joint immobility were studied at the molecular level
and changes in gene expression in the posterior capsule
are described.
The role of mechanical stimulation in joint homeosta-
sis has been examined in various experimental models
designed to reproduce the clinical features of osteoarth-
ritis (OA). Emphasis is often placed on the response to
surgical destabilization of the knee to induce OA and ana-
lysis of the articular cartilage conducted to interrogate dis-
ease pathways [38, 43]. Few studies have considered the
contribution of immobilization in the development and
progression of OA and the literature is dominated with
end-stage OA disease studies. We examined the profile of
expression of genes in capsule samples obtained from
patients with end-stage knee OA with or without knee
flexion contractures and reported differential expression
of 4 genes previously associated with fibrosis [44]. The
broad spectrum of factors likely to contribute to the differ-
ential expression of genes in clinical studies limits the ex-
tent of the conclusions and animal studies provide an
alternative. Dynamic flexion of the mouse joint and forced
flexion/extension exercise applied to destabilized rat joints
favored the development of OA [45]. In the mouse model
of OA, immobility induced by prolonged anesthesia or by
sciatic neurectomy prevented OA up to 12 weeks postsur-
gery [45]. Microarray analysis of genes expressed in the
whole joint of those animals revealed induction of protease
genes known to contribute to the degradation of the cartil-
age matrix that was prevented when joints were immobi-
lized [45]. The authors concluded that immobilization
prevented murine OA and the expression of cartilageproteases. The complex nature of animal OA models
does not allow for distinguishing between a response
to joint damage performed to induce OA and a pure
mechanotransductive response. Similarly, whole joints
were used to perform microarray analysis and the con-
tribution of individual tissue structures to differential
expression could not be established [45]. Our model of
immobilization-induced knee flexion contractures and
sham operated controls was designed to isolate the joint re-
sponse to immobilization and previously published results
indicate a detrimental role of immobilization on mechanical
function, cartilage structure and capsule elasticity. The
cartilage response to immobilization was indicative of
degeneration; loss of chondrocytes, decreased collagen
matrix staining and irregularity of the superficial layer
all supporting a degenerative process triggered by the
absence of mechanical stimulation [20, 21].
There are limitations to the microarray analysis of the
posterior knee joint capsule in the study of joint contrac-
tures. In this study, we focused our analysis on the cap-
sule and were not able to determine the role that other
soft tissues might have in joint contractures. The poster-
ior knee capsule is composed of different types of cells,
mainly fibroblasts but also adipocytes, synoviocytes, and
endothelial cells all potentially contributing to changes
in gene expression. Another limitation is inherent in the
microarray experiment itself and the correlation between
the levels of mRNA and of protein is tentative at best
[46]. Previous studies have reported differences as high
as 30 % of the transcripts identified as differentially
expressed by microarrays and changes in the correspond-
ing protein levels and have attributed the poor correlation
to the limited ability to measure protein levels. The level
of protein is likely to be the main contributing factor to
biological relevance, and justified the choice of assessing
tissue protein levels for validation purposes.
The demonstration of dynamic changes of gene expres-
sion in the posterior knee capsule reflects the phenotypic
joint response to immobilization over time and provides
an opportunity for assessment of within patient changes
during the progression of knee contractures as well as
treatment response. The profile of capsule gene expression
could be used to predict the prevalence of knee flexion
contractures and outcome of TKA or of an ICU stay with
an opportunity to apply preventive physical therapy prior
to the development of irreversible knee flexion contrac-
tures in those patients.
Methods
Animals
Male adult Dark Agouti rats 12 weeks of age and weigh-
ing approximately 325 g (Charles River Laboratories,
St-Constant, Quebec, Canada) were kept in an animal-care
facility with strict compliance to care and usage protocols
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tee. Rats were housed individually in standard cages and
maintained under 12- h light/12-h dark conditions at an
ambient temperature of 21 °C and fed a standard rat diet
(dry food) and water ad libitum.
Surgical procedures
We immobilized the knee joint of one hind limb of the
rats using an internal system implanted surgically as
previously described [12]. The knee remained in 135°
flexion throughout the duration of the immobilization
period and developed a knee flexion contracture [12].
While the anterior joint capsule is stretched, the poster-
ior knee capsule is relaxed and structural changes, with
time, will cause biomechanical restrictions. This was the
rationale for focusing data collection on the posterior
capsule in this model. The control group corresponded
to sham operated animals in which only the screws were
implanted.
Experimental design
For each time point: 1, 2, 4, 8, and 16 weeks, we immo-
bilized 8 rats and performed sham surgeries on 8 control
animals. At the end of the immobilization period, animals
were euthanized and the posterior knee joint capsules of
the operated legs were harvested for genome-wide expres-
sion and histological analyses.
RNA isolation
Individual capsules were submerged in 200 μL of ice
cold RNAlater® solution and stored at 4 °C overnight,
allowing for diffusion of the solution into the tissue.
Capsules were transferred into 0.5 ml of ice cold TRIzol®,
homogenized, and total RNA was isolated using the man-
ufacturer’s protocol (Invitrogen Life Technology, USA).
Extracted RNA was dissolved in 10 μL of RNase free
water, treated with DNAse, and stored at −80 °C until all
80 samples were collected. RNA yield and integrity was
determined on one μL of extracted RNA using the 2100
BioAnalyzer (Agilent, USA) and the Quant-IT RNA Assay
Kit, including pre-diluted RNA standards (Invitrogen Life
Technology, USA). For each time point, 8 RNA samples; 4
from the sham operated group and 4 from the immobi-
lized group, were selected based on similar quantity and
quality of extracted RNA and used for analysis on arrays.
cRNA synthesis, labeling and hybridization
Preparation of cRNA probes, hybridization and scanning
of arrays were performed at the Genome Quebec facil-
ity (Montreal, Quebec, Canada) using the Affymetrix
GeneChips® microarray platform and protocols. Total
RNA was first reversed transcribed following by RNase
H-mediated second-strand cDNA synthesis. The double-
stranded cDNA was purified and served as a template forthe transcription of biotinylated cRNAs. A second cycle of
cDNA synthesis was performed to generate biotinylated
cRNA and the amplification factor was 400x. For each
harvested knee joint capsule, a biotinylated labeled cRNA
sample was hybridized to a single-color array: Rat Genome
230 2.0 Array (Affymetrix), comprising over 31,000 probe
sets representing 28,700 well-substantiated rat genes. All
probe arrays were hybridized simultaneously for 17 h at
45 °C with constant rotation using an automated system
then washed and stained in the Affymetrix Station 400
and scanned by the Affymetrix GeneChip® Scanner 3000
(Affymetrix Technologies). The images from arrays were
analyzed to create CEL files.
Preprocessing of microarray data
The Affymetrix dataset contains data from 40 arrays
measuring gene expression in sham-operated and immo-
bilized knee joint capsules harvested at 1, 2, 4, 8 and
16 weeks. Calculations and data extractions from CEL
files were performed in the R software environment.
For data extraction, “mas5” with target value of 100 and
“mas5calls” functions from the “affy” package were used
to generate expression values and detection calls respect-
ively. A filtering step was applied to the initial 31099
probe sets to remove probes with detection calls labeled
as “absent” across all five time points and corresponding
to 5616 probe sets (Fig. 1). For the remaining 25483 probe
sets, expression values less than 100 across the five time
points, corresponding to 8771 values, were excluded. The
expression values of the remaining 16712 probe sets were
used to calculate the median of the 5 replicates per probe,
at each time point and used for both fold change and
temporal expression analyses. The identity of the probe
sets was confirmed by comparing the target mRNA se-
quences on the Affymetrix Rat Genome 230 2.0 GeneChip®
with the National Center for Biotechnology Information
(NCBI) GenBank database.
Fold changes in expression, temporal expression and
clustering
The two data sets corresponding to time-series gene ex-
pression for sham-operated and for immobilized knees,
were analyzed independently (Fig. 1). For each series, ra-
tios of expression values of week 2, 4, 8 or 16 over week
1 values were calculated. For analysis of fold changes in
expression, median values were used and ratios with a
minimum of 1.5 fold change were counted (Fig. 2). For
temporal expression analysis, data were log 2 transformed
and probe sets with similar profiles of expression were
grouped using Cluster Analysis of Gene Expression Dynam-
ics (implemented in the program CAGED: http://dcom-
mon.bu.edu/xmlui/handle/2144/1290) (Fig. 3). CAGED uses
a Bayesian model-based clustering algorithm to merge ex-
pression profiles into clusters and detects the optimal
Wong et al. BMC Musculoskeletal Disorders  (2015) 16:125 Page 12 of 13number of clusters. A polynomial model of order 3 was as-
sumed for analysis and only probes with a fold change in ex-
pression higher or lower than 2 fold in at least one time
point were considered for functional analysis.
Functional analysis of candidate genes
The Gene Ontology (GO) enrichment analysis was con-
ducted using the Database for Annotation, Visualization,
and Integrated Discovery (DAVID/EASE version 6.7)
software [47]. To identify more specific GO terms, ana-
lyses were performed using default settings for terms of
the GO Biological Processes (BP_FAT), GO Molecular
Function categories (MF_FAT) and GO Cellular Compo-
nent (CC_FAT). Pathways potentially enriched in the list
of immobilization candidate genes were identified using
the Kyoto Encyclopedia of Genes and Genomes (KEGG)
and the Reactome databases of biological pathways [48, 49].
Human diseases associated with joint contractures or hyper
laxity: literature search
Previously reported joint capsule mRNA expression was
assigned based on biocuration of the literature for genes
and human diseases involving joint mobility and using
PubMed and Google Scholar search tools. The biological
terms used were the following: joint contractures, joint
laxity, joint capsule, fibroblasts and connective tissue, synovio-
cytes and capsule. A comparison between the immobilization
gene expression data generated from the current study
and the list of human genes associated with joint con-
tractures or joint hyper laxity was conducted to identify
common genes.
Immunohistochemistry and histological scoring
The altered expression of selected genes was confirmed
by immunohistochemistry performed on rat knee sections
prepared as previously described [50]. Primary anti-
bodies were diluted in water to the following dilutions:
PCK1 (bs5001R, Bioss, Woburn, MA, US) and PLCH
(GTX87708, GeneTex, Irvine, CA, US) to 1:750, HSP47
(LS-C137998, LifeSpan Biosciences, Seattle, WA, US)
to 1:2000 and P4HB (LS-B3137, LifeSpan Biosciences)
to 1:5000. Sections were incubated overnight at 4 °C,
except for HSP47 for which sections were incubated for
2 h at 4 °C. Sections stained with P4HB primary anti-
body were also incubated with MACH 4 Mouse Probe
(Biocare Medical). Positive staining was revealed with
MACH 4 HRP-Polymer (Biocare Medical) and Liquid
DAB Substrate Pack (HK103-5 K, BioGenex, Fremont,
CA, US). Sections were counterstained with Hematoxylin
(Thermo Electron Corporation, Pittsburgh, PA, US) and
mounted. Negative controls corresponded to the omission
of the primary antibodies and performing all other steps
of the staining protocol. Fields with approximately 50–100
fibroblasts stained positively with DAB were counted as apercentage of total cells by two independent examiners,
counts per field were averaged and the field with the
largest inter-rater difference per rat was removed. The
remaining three fields per rat were plotted and statis-
tical analysis was completed using the R environment.
The non-parametric Kruskal-Wallis test was used to
determine the statistical difference in protein staining
between sham-operated and immobilized capsule at
each time point. A p value <0.05 was interpreted as
statistically significant.
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